The latest prostate cancer news
In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has…
Researchers at Case Western Reserve University and the University of Washington, USA, expect to gain…
A novel targeted radionuclide alpha therapy for metastatic castration-resistant prostate cancer—225AC-NM600—has been shown to achieve…
Current guidelines used to plan salvage radiation treatments in patients with local recurrence of prostate…
In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate…
Prostate cancer is the most common cancer among men in the United States. Many patients…
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the three-year…
The Australian-led clinical trial ENZAMET has shown that the addition of hormone therapy with a…
Men taking either of the two most common oral medications for advanced prostate cancer who…
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center, USA, have identified a…